Corneal dystrophy is a group of genetic eye conditions in which abnormal material slowly builds up in the cornea, the clear front surface of your eye. There are more than 20 types, and most progress gradually over years or even decades. Some cause no noticeable symptoms for a long time, while others lead to pain, blurred vision, and significant vision loss that can interfere with reading, driving, and other daily activities.
What all corneal dystrophies share is that they’re inherited rather than caused by injury or infection, they usually affect both eyes, and they involve the accumulation of specific substances in one or more layers of the cornea. Beyond that, the differences between types matter a lot, because the layer affected determines what symptoms you experience and what treatments help.
How the Cornea’s Layers Relate to Different Types
The cornea has five main layers, and corneal dystrophies are classified by which layer is involved. The outermost layer (the epithelium) acts as a barrier. Beneath it sits a thin protective sheet called Bowman’s layer, then the thick middle layer (the stroma) that gives the cornea its structure and clarity. Deeper still is Descemet’s membrane, and finally the innermost layer of endothelial cells, which pump fluid out of the cornea to keep it transparent.
When a dystrophy targets the epithelium, the main problem is that the surface layer doesn’t adhere properly, leading to painful erosions. When it targets the stroma, abnormal protein deposits cloud the cornea. When it targets the endothelium, the pump cells die off and fluid accumulates, swelling and hazing the cornea from within.
Fuchs’ Dystrophy: The Most Common Type
Fuchs’ endothelial corneal dystrophy is by far the most common form. A national study using Medicare data found a prevalence of about 1.12% among Americans over 65, with higher rates in women and white patients. It’s driven by the progressive death of endothelial cells on the back surface of the cornea, combined with the formation of tiny bumps called guttae on Descemet’s membrane. As these pump cells decline, the cornea absorbs excess fluid and swells, gradually becoming hazy.
The disease involves a complex mix of genetic susceptibility and environmental triggers that create oxidative stress and mitochondrial damage in the endothelial cells. The result is a vicious cycle: cell loss leads to more stress on the remaining cells, which accelerates further loss. Symptoms typically start as blurred vision in the morning (when the cornea is most swollen after a night of closed eyes) and progress over years to all-day blurriness, glare, and difficulty with fine tasks like reading.
Stromal Dystrophies and Their Distinctive Deposits
Three classic stromal dystrophies are distinguished by the specific material that accumulates in the cornea’s middle layer. Each one produces a different pattern visible during an eye exam.
- Lattice dystrophy involves amyloid deposits that form fine branching lines, first appearing in the central cornea and extending outward. Over time, a diffuse haze develops across the stroma. It’s linked to mutations in the TGFBI gene, with at least 26 known mutations capable of causing this type.
- Granular dystrophy produces deposits of a glassy material called hyaline that look like white crumbs or snowflake-shaped opacities under the slit lamp. The areas between deposits remain clear, at least initially.
- Macular dystrophy involves mucopolysaccharide deposits that create diffuse grey-white cloudiness with no clear corneal areas between them. Unlike the other two, it can also thin the cornea.
A fourth type, sometimes called Avellino dystrophy, combines features of both granular and lattice dystrophy, with deposits containing both hyaline and amyloid. All of these tend to worsen with each decade of life, and recurrent corneal erosions (where the surface layer peels away) are a common complication, particularly with lattice dystrophy.
Epithelial Dystrophies and Recurrent Erosions
Epithelial basement membrane dystrophy (also called map-dot-fingerprint dystrophy) affects the outermost corneal layer. In many people it causes no symptoms at all. When it does, the hallmark problem is recurrent corneal erosion, where the surface epithelium separates from the layer beneath it.
These erosions cause sudden sharp pain, redness, light sensitivity, excessive tearing, and the feeling that something is stuck in your eye. Symptoms are most common on waking, because opening your eyes can physically lift the poorly attached surface layer. Episodes can happen repeatedly over months or years, with unpredictable gaps between them. For some people the erosions are a minor nuisance; for others they’re intensely painful and disruptive to sleep and daily life.
Genetics and Inheritance Patterns
Corneal dystrophies are genetic conditions, and many stromal types trace back to mutations in a single gene called TGFBI. Specific mutations in this gene are strongly associated with particular dystrophies. A single amino acid swap at one position in the gene’s protein causes Avellino dystrophy, while a different swap at the same position causes Reis-Bucklers dystrophy. Other positions determine whether you develop Thiel-Behnke or Groenouw dystrophy. This means genetic testing can sometimes confirm exactly which type you have.
Most stromal dystrophies follow an autosomal dominant pattern, meaning you only need to inherit one copy of the mutated gene from one parent to develop the condition. Macular dystrophy is an exception, following an autosomal recessive pattern (both parents must carry the mutation). Fuchs’ dystrophy has a more complex genetic picture, with multiple genes involved alongside environmental factors, though a specific repeat mutation in the TCF4 gene accounts for a large proportion of cases.
How Corneal Dystrophy Is Diagnosed
Diagnosis starts with a slit-lamp exam, where your eye doctor shines a narrow beam of light across the cornea and examines it under magnification. Each dystrophy type produces recognizable patterns: branching lines for lattice, breadcrumb-like white spots for granular, diffuse cloudiness for macular, and scattered bumps on the back surface for Fuchs’.
A newer imaging tool called anterior segment optical coherence tomography (AS-OCT) adds a cross-sectional view of the cornea’s layers. It can show exactly how deep deposits extend, whether Bowman’s layer has been disrupted, and how much the cornea has thickened from fluid buildup. In lattice dystrophy, for example, OCT reveals bright deposits concentrated in the front and middle layers of the stroma, with surface thinning above them. In granular dystrophy, bright deposits show up as distinct spots with normal-looking cornea between them. These imaging details help track progression and plan treatment timing.
Non-Surgical Treatment Options
For mild to moderate disease, several conservative approaches can manage symptoms and slow the impact on vision. The specific strategy depends on which layer is affected.
For Fuchs’ dystrophy and other conditions that cause corneal swelling, hypertonic saline drops (typically a 5% sodium chloride solution) are a first-line treatment. These concentrated salt drops draw excess fluid out of the cornea through osmosis, temporarily reducing swelling and improving clarity. They’re most effective when used shortly after waking, since corneal edema is worst in the morning. Some patients use the drops at five-minute intervals after getting up to clear their vision for the day.
Bandage contact lenses can protect the corneal surface in epithelial dystrophies, reducing pain from recurrent erosions and giving the epithelium a stable surface to heal against. In some cases, combining therapeutic soft lenses with hypertonic saline drops over about a week significantly reduces both swelling and symptoms. Anti-inflammatory drops may also be used to prevent blood vessel growth into the cornea and control inflammation.
When Surgery Becomes Necessary
When vision loss progresses to the point where it interferes with daily life, surgical options depend on the type and layer involved.
For Fuchs’ dystrophy, the standard treatment is now a partial-thickness corneal transplant that replaces only the damaged endothelial layer. Two main techniques exist. The newer approach (DMEK) transplants just the thin endothelial cell layer and its membrane. The slightly older approach (DSAEK) transplants a somewhat thicker tissue layer. Both produce excellent long-term vision, reaching about 20/25 on average. The key difference is recovery speed: eyes treated with DMEK reach their best vision in about 9 months on average, compared to roughly 16 months for DSAEK.
For stromal dystrophies, a full-thickness corneal transplant may eventually be needed if deposits become dense enough to block vision. Phototherapeutic keratectomy, a laser procedure that removes superficial corneal tissue, can treat deposits in the front layers and delay the need for transplant. However, deposits can recur in transplanted tissue over time, particularly in lattice and granular dystrophies, since the underlying genetic mutation still affects new cells that grow into the graft.
Living With Corneal Dystrophy
Because most corneal dystrophies progress over years to decades, many people live with mild forms for a long time before needing intervention. The practical impact varies enormously. Some people with epithelial dystrophy experience occasional morning eye pain but maintain good vision throughout life. Others with aggressive stromal or endothelial forms may face significant vision loss by middle age.
Protecting your eyes from UV light may matter more than usual, since ultraviolet exposure contributes to oxidative stress in the cornea, and oxidative damage is a key driver in Fuchs’ dystrophy. If you have a known family history, early screening allows for monitoring well before symptoms develop. And if you’re considering vision correction surgery like LASIK, a thorough corneal evaluation matters, because undiagnosed dystrophy can complicate outcomes or be worsened by the procedure.